Results for the Future of HCV Treatment (10/21/06) Survey
Was VRTX a choice in this survey regarding who might be a current investor? With future HCV treatments "most likely" being a cocktail of the different drug classes, I continue to be fascinated as to why investors continue to value VRTX so much. A single therapy drug is very unlikely (IMHO).